For example, hyperactivation of AKT signaling by phosphatase and tensin homolog (PTEN) loss impedes the trafficking of effector T cells to tumors, reduces the sensitivity of melanoma cells to T cell–mediated killing, and is correlated with inferior outcomes for patients treated with ICB (19, 20). Here, PTEN is linked to melanoma.